- Investing Ideas
- /
- U.S. Biotech Stocks
U.S. Biotech Stocks
Results
437
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
437 companies
GeoVax Labs
Market Cap: US$16.5m
A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
GOVX
US$0.64
7D
-3.1%
1Y
-74.1%
Athira Pharma
Market Cap: US$16.1m
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
ATHA
US$3.81
7D
-0.5%
1Y
-9.0%
NextCure
Market Cap: US$15.4m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$5.78
7D
2.2%
1Y
-65.8%
Lipocine
Market Cap: US$15.0m
A clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders.
LPCN
US$2.68
7D
-4.6%
1Y
-42.2%
BioVie
Market Cap: US$14.0m
A clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States.
BIVI
US$1.80
7D
-3.7%
1Y
-83.8%
Gelteq
Market Cap: US$14.0m
Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.
GELS
US$1.35
7D
-7.5%
1Y
n/a
Pharma-Bio Serv
Market Cap: US$13.8m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.60
7D
5.3%
1Y
-6.1%
Chemomab Therapeutics
Market Cap: US$13.5m
A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.
CMMB
US$2.50
7D
-4.9%
1Y
-60.2%
Phio Pharmaceuticals
Market Cap: US$12.8m
A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.
PHIO
US$2.20
7D
4.3%
1Y
-38.4%
Polyrizon
Market Cap: US$12.7m
A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
PLRZ
US$1.06
7D
1.9%
1Y
n/a
Aptorum Group
Market Cap: US$12.6m
Through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
APM
US$1.79
7D
-6.8%
1Y
-4.5%
NovaBay Pharmaceuticals
Market Cap: US$12.6m
Does not have significant operations.
NBY
US$2.14
7D
10.3%
1Y
193.2%
TherapeuticsMD
Market Cap: US$12.5m
Operates as a pharmaceutical royalty company in the United States.
TXMD
US$1.06
7D
-1.9%
1Y
-35.8%
Marker Therapeutics
Market Cap: US$11.8m
A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR
US$0.88
7D
-8.2%
1Y
-67.9%
HOOKIPA Pharma
Market Cap: US$11.5m
A clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform.
HOOK
US$0.88
7D
-2.2%
1Y
-79.0%
Sensei Biotherapeutics
Market Cap: US$11.4m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$8.77
7D
-5.7%
1Y
-21.1%
Processa Pharmaceuticals
Market Cap: US$10.6m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.19
7D
-6.9%
1Y
-85.0%
Evoke Pharma
Market Cap: US$10.6m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$5.01
7D
-1.4%
1Y
-1.4%
Cyclerion Therapeutics
Market Cap: US$10.4m
A biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.
CYCN
US$2.73
7D
16.7%
1Y
1.1%
IM Cannabis
Market Cap: US$9.7m
Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
IMCC
US$1.78
7D
-9.6%
1Y
-20.9%
ESSA Pharma
Market Cap: US$9.5m
A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
EPIX
US$0.20
7D
-4.6%
1Y
-96.8%
IN8bio
Market Cap: US$9.5m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
INAB
US$2.09
7D
1.5%
1Y
-75.6%
VivoSim Labs
Market Cap: US$9.2m
A pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.
VIVS
US$3.45
7D
-12.2%
1Y
-34.5%
Kiora Pharmaceuticals
Market Cap: US$9.0m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
KPRX
US$2.57
7D
-3.0%
1Y
-25.4%
Kazia Therapeutics
Market Cap: US$8.8m
Operates as an oncology-focused biotechnology company in South Korea.
KZIA
US$7.33
7D
-5.2%
1Y
-59.8%
Galmed Pharmaceuticals
Market Cap: US$7.9m
A biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.
GLMD
US$1.38
7D
-8.6%
1Y
-81.2%
NuCana
Market Cap: US$7.6m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.
NCNA
US$3.98
7D
-0.3%
1Y
-99.3%
Cardio Diagnostics Holdings
Market Cap: US$7.5m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$4.06
7D
4.9%
1Y
-45.9%
Alzamend Neuro
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.36
7D
-5.2%
1Y
-84.7%
Sunshine Biopharma
Market Cap: US$7.1m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.52
7D
3.4%
1Y
-50.5%
Sonoma Pharmaceuticals
Market Cap: US$6.7m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$4.06
7D
-4.7%
1Y
26.5%
Ensysce Biosciences
Market Cap: US$6.6m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.26
7D
7.6%
1Y
-44.8%
China Pharma Holdings
Market Cap: US$6.5m
Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.
CPHI
US$1.95
7D
-0.8%
1Y
-20.1%
cbdMD
Market Cap: US$6.0m
Produces and distributes various cannabidiol (CBD) products in the United States.
YCBD
US$0.60
7D
-16.3%
1Y
-84.0%
Aptevo Therapeutics
Market Cap: US$5.9m
A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.
APVO
US$1.60
7D
-19.2%
1Y
-98.8%
Titan Pharmaceuticals
Market Cap: US$5.7m
Does not have significant operations.
TTNP
US$4.03
7D
-3.6%
1Y
-23.4%